Yinglong Hou

Dr. Yinglong Hou


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2014 in Medical & Biological Engineering & Computing
Verified
Journal Article
Closed access
PDF file
PLPeng Li
Peng Li
CLChengyu Liu
Chengyu Liu
KLKe Li
Ke Li
DZDingchang Zheng
Dingchang Zheng
CLChangchun Liu
Changchun Liu
YHYinglong Hou
Yinglong Hou

5 December 2012 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
CZChun Ting Zhao
Chun Ting Zhao
MWMei Wang
Mei Wang
CSChung Wah Siu
Chung Wah Siu
YHYinglong Hou
Yinglong Hou
TWTian Wang
Tian Wang
KYKai Hang Yiu
Kai Hang Yiu
Background: Endothelial progenitor cells (EPCs) are responsible for angiogenesis and maintenance of microvascular integrity, the number of EPCs is correlated with oxidative stress. Their relation to myocardial dysfunction in patients with type 2 diabetes mellitus (T2DM) is nonetheless unknown. Methods: Eighty-seven patients with T2DM and no history of coronary artery disease were recruited. Transthoracic echocardiography and detailed evaluation of left ventricular (LV) systolic function by 2-dimensional (2D) speckle tracking derived strain analysis in 3 orthogonal directions was performed. Four subpopulations of EPCs, including CD34+, CD133+, CD34+/kinase insert domain-containing receptor (KDR) + and CD133+/KDR + EPCs, were measured by flow cytometry. Oxidative stress was assessed by superoxide dismutase (SOD). Results: The mean age of the patients was 62 ± 9 years and 39.6% were male. Those with an impaired longitudinal strain had a lower number of CD34+ EPCs (2.82 ± 1.87% vs. 3.74 ± 2.12%, P < 0.05) than those with preserved longitudinal strain. When compared with those with preserved circumferential strain, patients with an impaired circumferential strain had a lower number of CD34+ EPCs (2.63 ± 1.80% vs. 3.87 ± 2.10%, P < 0.01) and SOD level (0.13 ± 0.06U/ml vs. 0.20 ± 0.08U/ml, P < 0.01). Patients with an impaired radial strain nonetheless had a lower number of CD34+ EPCs (2.62 ± 2.08% vs. 3.69 ± 1.99%, P < 0.05). Multivariate analysis demonstrated that only impaired global circumferential strain remained significantly associated with CD34 + EPCs and SOD. Conclusions: LV global circumferential strain was independently associated with number of CD34+ EPCs and SOD. These findings suggest that myocardial dysfunction in patients with T2DM is related to depletion of EPCs and increased oxidative stress.

27 March 2012 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
XWXing Wanjia
Xing Wanjia
WCWang Chenggang
Wang Chenggang
WAWang Aihong
Wang Aihong
YXYang Xiaomei
Yang Xiaomei
JZJiajun Zhao
Jiajun Zhao
LGLing Gao
Ling Gao
Background: Serum lipid profiles may be influenced by thyroid function, but the detailed mechanism remains unclear. Increasing evidence suggests that thyrotropin (TSH) may exert extra-thyroidal effects. The goal of this study was to evaluate the relationship between serum TSH levels and the lipid profiles in euthyroid non-smokers with newly diagnosed asymptomatic coronary heart disease (CHD). Methods: This was a retrospective study of 406 euthyroid non-smokers (187 males and 219 females) with newly diagnosed asymptomatic CHD from 2004 to 2010 in Jinan, China. Lipid parameters and the levels of TSH, FT3, and FT4 were determined. Multiple linear regression analysis and Logistic regression analysis were used to assess the influence of TSH on the lipid profiles and the risks of dyslipidemia. Results: The TSH level, even within the normal range, was positively and linearly correlated with total cholesterol (TC), non-high density lipoprotein cholesterol (non-HDL-C) and triglycerides (TG) (Beta = 0.173, 0.181 and 0.103, respectively, P < 0.01 in all). With 1 mIU/L rise of TSH, the levels of TC, TG and non-HDL-C will increase by 1.010, 1.064, and 1.062 mmol/L, respectively. The odds ratio of hypercholesterolemia and hypertriglyceridemia with respect to the serum TSH level was 1.640 (95% CI 1.199-2.243, P = 0.002) and 1.349 (95% CI 1.054-1.726, P = 0.017), respectively. Conclusions: TSH levels were correlated in a positive linear manner with the TC, non-HDL-C and TG levels in euthyroid non-smokers with newly diagnosed asymptomatic CHD. TSH in the upper limits of the reference range might exert adverse effects on lipid profiles and thus representing as a risk factor for hypercholesterolemia and hypertriglyceridemia in the context of CHD.

15 February 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SMShenzhou Ma
Shenzhou Ma
YFYan Feng
Yan Feng
YHYinglong Hou
Yinglong Hou
Objective: New drugs to block the occurrence of atrial fibrillation (AF) based on atrial structural remodeling (ASR) are urgently needed. The purpose of this study was to study the role of intermedin 1-53 (IMD1-53) in ASR and AF formation in rats after myocardial infarction (MI). Material and methods: Heart failure was induced by MI in rats. Fourteen days after MI surgery, rats with heart failure were randomized into control (untreated MI group, n = 10) and IMD-treated (n = 10) groups. The MI group and sham group received saline injections. The rats in the IMD group received IMD1-53, 10 nmol/kg/day intraperitoneally for 4 weeks. The AF inducibility and atrial effective refractory period (AERP) were assessed with an electrophysiology test. Additionally, the left-atrial diameter was determined, and heart function and hemodynamic tests were performed. We detected the area changes of myocardial fibrosis in the left atrium using Masson staining. To detect the protein expression and mRNA expression of transforming growth factor-β1 (TGF-β1), α-SMA, collagen Ⅰ, collagen III, and NADPH oxidase (Nox4) in the myocardial fibroblasts and left atrium, we used the Western blot method and real-time quantitative polymerase chain reaction (PCR) assays. Results: Compared with the MI group, IMD1-53 treatment decreased the left-atrial diameter and improved cardiac function, while it also improved the left-ventricle end-diastolic pressure (LVEDP). IMD1-53 treatment attenuated AERP prolongation and reduced atrial fibrillation inducibility in the IMD group. In vivo, IMD1-53 reduced the left-atrial fibrosis content in the heart after MI surgery and inhibited the mRNA and protein expression of collagen type Ⅰ and III. IMD1-53 also inhibited the expression of TGF-β1, α-SMA, and Nox4 both in mRNA and protein. In vivo, we found that IMD1-53 inhibited the phosphorylation of Smad3. In vitro, we found that the downregulated expression of Nox4 was partly dependent on the TGF-β1/ALK5 pathway. Conclusions: IMD1-53 decreased the duration and inducibility of AF and atrial fibrosis in the rats after MI operation. The possible mechanisms are related to the inhibition of TGF-β1/Smad3-related fibrosis and TGF-β1/Nox4 activity. Therefore, IMD1-53 may be a promising upstream treatment drug to prevent AF.

12 October 2022 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
MRMan-Yi Ren
Man-Yi Ren
YZYong Zhang
Yong Zhang
YZYu-Jiao Zhang
Yu-Jiao Zhang
MGMei Gao
Mei Gao
CSCai-Hua Sang
Cai-Hua Sang
YHYinglong Hou
Yinglong Hou
More than three types of ECG manifestations in one patient with dual atrioventricular nodal non-reentrant tachycardia (DAVNNT) are rare. We report a 51-year-old male patient with DAVNNT consisting of six types of ECG patterns leading to tachycardia-induced cardiomyopathy. After radiofrequency ablation of the slow pathway, DAVNNT was eliminated and cardiac function was restored.

28 August 2024
Verified
Book Chapter
Open access
PDF file
YZYujiao Zhang
Yujiao Zhang
ZLZhan Li
Zhan Li
MGMei Gao
Mei Gao
YHYinglong Hou
Yinglong Hou
In order to improve the integrated management of atrial fibrillation (AF), the control of risk factors is becoming increasingly important as a means of upstream treatment. At present, the risk factors for the occurrence and recurrence of AF mainly include age, smoking, drinking, lack of exercise, hypertension, diabetes, obesity, OSA, etc. However, more and more studies have found that some novel risk factors play an important role in the occurrence and recurrence of AF, such as hyperuricemia, hyperhomocysteinemia, hyperbilirubinemia, nonalcoholic fatty liver disease (NAFLD), dyslipidemia, hypoalbuminemia, autoimmune diseases. In this chapter, we focus on several novel risk factors for AF, which can not only improve our understanding of the pathophysiology of AF but also facilitate the adjustment of clinical strategies to reduce the occurrence and recurrence of AF.